Royalty Pharma plc (RPRX) Insider Trading
- $144,650,981.16
- $569,823,010.16
- Jan. 4, 2024
- Rory B Riggs
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 28, 2021 | Director | 167,448 | $42.11 | Sell | $7,051,235.28 | |
| June 25, 2021 | Director | 666,464 | $42.72 | Sell | $28,471,342.08 | |
| June 10, 2021 | EVP | 70,000 | $46.49 | Sell | $3,254,300.00 | |
| June 7, 2021 | EVP | 16,568 | $47.02 | Sell | $779,027.36 | |
| June 4, 2021 | EVP | 16,566 | $45.13 | Sell | $747,623.58 | |
| June 2, 2021 | EVP | 14,566 | $41.52 | Sell | $604,780.32 | |
| April 14, 2021 | EVP | 69,822 | $42.13 | Sell | $2,941,600.86 | |
| April 12, 2021 | EVP | 449 | $42.32 | Sell | $19,001.68 | |
| March 22, 2021 | EVP | 43,927 | $46.32 | Sell | $2,034,698.64 | |
| March 2, 2021 | EVP | 125,000 | $46.94 | Sell | $5,867,500.00 | |
| March 2, 2021 | CFO | 100,000 | $46.94 | Sell | $4,694,000.00 | |
| Feb. 25, 2021 | Director | 25,700 | $46.83 | Buy | $1,203,531.00 | |
| Dec. 18, 2020 | Major Shareholder | 7,301,050 | $43.92 | Sell | $320,662,116.00 | |
| Oct. 20, 2020 | Director | 463,200 | $42.00 | Sell | $19,454,400.00 | |
| June 18, 2020 | CFO | 1,500 | $28.00 | Buy | $42,000.00 | |
| June 18, 2020 | Major Shareholder | 3,000,000 | $28.00 | Buy | $84,000,000.00 | |
| June 18, 2020 | EVP | 3,000 | $28.00 | Buy | $84,000.00 | |
| June 18, 2020 | CEO | 20,000 | $28.00 | Buy | $560,000.00 | |
| June 18, 2020 | Director | 1,500,000 | $28.00 | Buy | $42,000,000.00 |
Insiders are both buying and selling Royalty Pharma plc stock.
The insider traders at Royalty Pharma plc are: Rory B Riggs, George W Lloyd, Terrance P Coyne, Pablo G Legorreta, James F Reddoch, Mario Germano Giuliani, Marshall Urist, Henry A Fernandez, Adage Capital Partners Gp, L.L, James F. Reddoch, William E Ford, Avara Management Ltd, and 1978 Sicaf Sif S.A. - Gg St Gg
The most active insider trader at Royalty Pharma plc is Rory B Riggs with 18 trades.
Adage Capital Partners Gp, L.L has sold the most Royalty Pharma plc stock with a total value of $641,324,232.00.
Adage Capital Partners Gp, L.L has bought the most Royalty Pharma plc stock with a total value of $168,000,000.00.
The most recent insider trade for Royalty Pharma plc was on Jan. 4, 2024.
The single biggest insider buy for Royalty Pharma plc was from Adage Capital Partners Gp, L.L with a total value of $84,000,000.00 on June 18, 2020.
The single biggest insider sell for Royalty Pharma plc was from Adage Capital Partners Gp, L.L with a total value of $320,662,116.00 on Dec. 18, 2020.